HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and genetic analysis of progressive dystonia with diurnal variation.

Abstract
We examined 17 patients with progressive dystonia with diurnal variation, a dominantly inherited, generalized dystonia that begins in childhood. Dystonia was typically least severe in the morning, increased as the day continued, and markedly improved with low doses of carbidopa-levodopa. We also studied the patient's parents, children, and siblings from seven families. We observed a spectrum of neurologic involvement, phenotypic variability among siblings, and incomplete genetic penetrance. Progression of motor impairment over several years, which reaches a plateau during late adolescence, is useful in distinguishing progressive dystonia with diurnal variation from cerebral palsy and degenerative disorders. It is important to recognize the subtle, as well the extreme, manifestations of progressive dystonia with diurnal variation because it is treatable. Genetic counseling must consider that mildly affected parents with little or no disability may have profoundly affected children. Appreciation of the phenotypic variability and degree of genetic penetrance will permit detailed genetic and biochemical analyses.
AuthorsJ K Fink, P D Ravin, M Filling-Katz, C E Argoff, M Hallett
JournalArchives of neurology (Arch Neurol) Vol. 48 Issue 9 Pg. 908-11 (Sep 1991) ISSN: 0003-9942 [Print] United States
PMID1953413 (Publication Type: Journal Article)
Chemical References
  • Drug Combinations
  • Levodopa
  • Carbidopa
Topics
  • Adolescent
  • Adult
  • Carbidopa (therapeutic use)
  • Child
  • Child, Preschool
  • Circadian Rhythm
  • Drug Combinations
  • Dystonia (complications, drug therapy, genetics, physiopathology)
  • Female
  • Humans
  • Levodopa (therapeutic use)
  • Male
  • Middle Aged
  • Pedigree

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: